Hero Image

Life at MSD in the Philippines

We aim to improve lives through our innovative medicines and solutions.

We respond to the call to cure and the quest to invent for life for a better tomorrow.

Guided by our purpose, we make a difference in the lives of people globally through our innovative medicines, vaccines, and animal health products.

Our purpose

We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines.

Our aspiration

We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals.

Our Ways Of Working

Win as one team

Focus on what matters

Act with urgency

Experiment, learn and adapt

Embrace diversity and inclusion

Speak up and be open-minded

We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities.

 

 

We walk the talk

If you want to learn about our culture, start with our inventors.

MSD in the Philippines harnesses lessons from the pandemic for a more human-centric workplace

Andreas Riedel, President and Managing Director of MSD in the Philippines, addresses employees as the company launched its new strategic priorities and hybrid work setup. Over the last two years of the pandemic, the pharmaceutical industry needed to step up in ensuring access to life-saving medicines and vaccines amid unprecedented challenges. For global healthcare leader […]

Read more

Next: MSD in the Philippines harnesses lessons from the pandemic for a more human-centric workplace

MSD in the Philippines announces Andreas Riedel as new President and Managing Director

MSD in the Philippines (NYSE: MRK), a trade name of Merck & Co., Inc, Kenilworth, NJ, USA, today announced the appointment of Mr. Andreas Riedel as its new President and Managing Director. He succeeds Dr. Beaver Tamesis who has announced his retirement from the pharmaceutical company. The leadership transition reaffirms the company’s commitment of inventing […]

Read more

Next: MSD in the Philippines announces Andreas Riedel as new President and Managing Director

MSD in the Philippines harnesses lessons from the pandemic for a more human-centric workplace

Andreas Riedel, President and Managing Director of MSD in the Philippines, addresses employees as the company launched its new strategic priorities and hybrid work setup. Over the last two years of the pandemic, the pharmaceutical industry needed to step up in ensuring access to life-saving medicines and vaccines amid unprecedented challenges. For global healthcare leader […]

Read more

Next: MSD in the Philippines harnesses lessons from the pandemic for a more human-centric workplace

MSD in the Philippines announces Andreas Riedel as new President and Managing Director

MSD in the Philippines (NYSE: MRK), a trade name of Merck & Co., Inc, Kenilworth, NJ, USA, today announced the appointment of Mr. Andreas Riedel as its new President and Managing Director. He succeeds Dr. Beaver Tamesis who has announced his retirement from the pharmaceutical company. The leadership transition reaffirms the company’s commitment of inventing […]

Read more

Next: MSD in the Philippines announces Andreas Riedel as new President and Managing Director

Previous
Next